Compare with ALEMBIC LTD - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs ALEMBIC LTD - Comparison Results

ALEMBIC LTD 
   Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES ALEMBIC LTD ALKEM LABORATORIES/
ALEMBIC LTD
 
P/E (TTM) x - 73.7 - View Chart
P/BV x 6.6 2.6 253.8% View Chart
Dividend Yield % 0.7 0.4 167.4%  

Financials

 ALKEM LABORATORIES   ALEMBIC LTD
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
ALEMBIC LTD
Mar-18
ALKEM LABORATORIES/
ALEMBIC LTD
5-Yr Chart
Click to enlarge
High Rs1,58972 2,206.9%   
Low Rs1,23234 3,634.2%   
Sales per share (Unadj.) Rs417.54.7 8,881.0%  
Earnings per share (Unadj.) Rs56.36.1 922.3%  
Cash flow per share (Unadj.) Rs64.76.2 1,036.1%  
Dividends per share (Unadj.) Rs12.700.20 6,350.0%  
Dividend yield (eoy) %0.90.4 238.4%  
Book value per share (Unadj.) Rs292.940.7 720.4%  
Shares outstanding (eoy) m119.57267.03 44.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.411.3 30.0%   
Avg P/E ratio x25.18.7 288.8%  
P/CF ratio (eoy) x21.88.5 257.1%  
Price / Book Value ratio x4.81.3 369.8%  
Dividend payout %22.63.3 688.5%   
Avg Mkt Cap Rs m168,65314,139 1,192.8%   
No. of employees `000NANA-   
Total wages/salary Rs m9,171207 4,422.0%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m49,9151,255 3,976.7%  
Other income Rs m1,645370 444.4%   
Total revenues Rs m51,5611,625 3,172.2%   
Gross profit Rs m8,482111 7,634.8%  
Depreciation Rs m1,00638 2,660.8%   
Interest Rs m6712 39,447.1%   
Profit before tax Rs m8,451442 1,912.9%   
Minority Interest Rs m-1140-   
Prior Period Items Rs m01,212 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,60624 6,705.6%   
Profit after tax Rs m6,7311,630 413.0%  
Gross profit margin %17.08.9 192.0%  
Effective tax rate %19.05.4 350.6%   
Net profit margin %13.5129.8 10.4%  
BALANCE SHEET DATA
Current assets Rs m27,0621,867 1,449.4%   
Current liabilities Rs m15,324591 2,591.9%   
Net working cap to sales %23.5101.6 23.1%  
Current ratio x1.83.2 55.9%  
Inventory Days Days6794 70.6%  
Debtors Days Days4174 56.1%  
Net fixed assets Rs m12,6101,791 704.1%   
Share capital Rs m239534 44.8%   
"Free" reserves Rs m34,49010,324 334.1%   
Net worth Rs m35,02710,858 322.6%   
Long term debt Rs m1,21241 2,940.8%   
Total assets Rs m54,38711,591 469.2%  
Interest coverage x13.6260.9 5.2%   
Debt to equity ratio x00 911.6%  
Sales to assets ratio x0.90.1 847.5%   
Return on assets %13.614.1 96.7%  
Return on equity %19.215.0 128.0%  
Return on capital %24.915.2 163.6%  
Exports to sales %12.91.5 837.5%   
Imports to sales %3.121.0 14.7%   
Exports (fob) Rs m6,46119 33,304.6%   
Imports (cif) Rs m1,540263 584.9%   
Fx inflow Rs m6,56319 33,831.4%   
Fx outflow Rs m3,012264 1,141.6%   
Net fx Rs m3,552-244 -1,453.1%   
CASH FLOW
From Operations Rs m7,259236 3,078.2%  
From Investments Rs m1,864-224 -832.2%  
From Financial Activity Rs m-9,273-27 34,859.8%  
Net Cashflow Rs m-150-15 1,013.5%  

Share Holding

Indian Promoters % 66.9 64.0 104.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 33.1 0.2 16,550.0%  
FIIs % 0.0 9.7 -  
ADR/GDR % 0.0 0.0 -  
Free float % 0.0 26.1 -  
Shareholders   68,381 54,701 125.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   ABBOTT INDIA  JUBILANT LIFE SCIENCES  DIVIS LABORATORIES  PIRAMAL ENTERPRISES  NATCO PHARMA  

Compare ALKEM LABORATORIES With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex's Journey From 640 Points Down to 2,000 Points Up(Podcast)

What a week it was! While crude oil prices dragged the Indian stock markets lower, finance minister Nirmala Sitharaman's boosters sent markets soaring and how!

Related Views on News

ALEMBIC LTD Announces Quarterly Results (1QFY20); Net Profit Down 70.9% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, ALEMBIC LTD has posted a net profit of Rs 20 m (down 70.9% YoY). Sales on the other hand came in at Rs 260 m (down 41.5% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (4QFY19); Net Profit Down 14.6% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, ALEMBIC LTD has posted a net profit of Rs 40 m (down 14.6% YoY). Sales on the other hand came in at Rs 253 m (down 23.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (3QFY19); Net Profit Down 41.9% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, ALEMBIC LTD has posted a net profit of Rs 32 m (down 41.9% YoY). Sales on the other hand came in at Rs 243 m (down 18.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (2QFY19); Net Profit Up 4.0% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, ALEMBIC LTD has posted a net profit of Rs 294 m (up 4.0% YoY). Sales on the other hand came in at Rs 336 m (up 3.1% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (1QFY19); Net Profit Up 106.9% (Quarterly Result Update)

Aug 10, 2018 | Updated on Aug 10, 2018

For the quarter ended June 2018, ALEMBIC LTD has posted a net profit of Rs 69 m (up 106.9% YoY). Sales on the other hand came in at Rs 445 m (up 50.4% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

The 5 Best Trading Opportunities I've Spotted(Profit Hunter)

Sep 13, 2019

These 10 auto stocks should be in your watchlist for the next 32 months. Paste them on your workstation NOW.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Sep 20, 2019 (Close)

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES - PFIZER COMPARISON

COMPARE ALKEM LABORATORIES WITH

MARKET STATS